NEW YORK (GenomeWeb News) – NanoString Technologies said after the close of markets Wednesday that it has secured an exclusive option from Massachusetts General Hospital to license intellectual property related to a method of multiplexed protein analysis using the company's nCounter Analysis System.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.